Your Article Summary
See Latest ArticlesCost of Gestational Diabetes Mellitus in the United States in 2007
Population Health Management, 06/18/09
Chen Y et al. - GDM imposes a significant economic burden. These estimates of the economic burden of GDM are likely conservative because the authors focus on near-term medical costs, omitting the increased risk for long-term sequelae.
Related Articles
Medical care costs of patients with rheumatoid arthritis during the prebiologics period in Japan: a large prospective observational cohort study
Modern Rheumatology, 10/15/09
Relevance Score: 70%
Much Cheaper, Almost as Good: Decrementally Cost-Effective Medical Innovation
Annals of Internal Medicine, 11/04/09
Relevance Score: 69%
Managing complex patients on a medical psychiatric unit: An observational study of university hospital costs associated with medical service use, length of stay, and psychiatric intervention
Journal of Psychosomatic Research, 10/09/09
Relevance Score: 69%
Cost-effectiveness analysis of trastuzumab (herceptin) in HER2-overexpressed metastatic breast cancer
American Journal of Clinical Oncology, 10/06/09
Relevance Score: 69%
Good Research Practices for Measuring Drug Costs in Cost Effectiveness Analyses: An Industry Perspective: The ISPOR Drug Cost Task Force Report-Part V
Value in Health, 10/29/09
Relevance Score: 68%
Today in Economics of Medicine...keeping you current
Receive free subspecialty "5-minute updates" via email
Keep Out of the OIG's Crosshairs in 2010
Outpatient Surgery, 11/30/09
Rising mortality and life expectancy differentials by lifetime earnings in the United States
Journal of Health Economics, 11/24/09
Pharmaceutical cost control in primary care: opinion and contributions by healthcare professionals
BMC Health Services Research, 11/23/09